Is CRSPR Stock a Buy?
Interest in CRISPR Therapeutics AG (NASDAQ:CRSP) peaked in early 2021, with shares reaching nearly $200, but the stock hasn’t reached that level again. …
ProShares UltraShort 20+ Year Treasury
Interest in CRISPR Therapeutics AG (NASDAQ:CRSP) peaked in early 2021, with shares reaching nearly $200, but the stock hasn’t reached that level again. …